Republic of the Philippines

UNIVERSITY OF NORTHERN PHILIPPINES

Tamag, Vigan City
2700 Ilocos Sur

College of Nursing
Website: www.unp.edu.ph Mail: unp_nursingvc@yahoo.com
CP# 09177148749, 09175785986

DRUG STUDY
NAME OF DOSAGE, MECHANIS INDICATIONS CONTRAINDICATIO ADVERSE NURSING
DRUG FREQUENCY, M OF NS EFFECTS RESPONSIBILITIES
ROUTE, ACTION
DURATION OF
ADMINISTRATI
ON
Generic Name: Dosage: Azithromycin  Treatment of - Contraindicated in CNS: Before administration:
Azithromycin 500mg tab blocks lower respiratory patients - Fatigue - Assess for patients
transpeptidatio infections: Acute hypertensive to - Headache medical history
Brand Name: Frequency: n by binding to bacterial azithromycin, - Somnolence including
Losec OD for 3 doses 50s ribosomal exacerbations of erythromycin, or - Dizziness hypersensitivity to
subunit of COPD other macrolide or CV: azithromycin,
Classification: Route of susceptible  Treatment of ketolide antibiotics - Chest pain erythromycin, or any
Antibiotics Administration: organisms and lower respiratory and in those with - Palpitations macrolide antibiotic;
Oral disrupting infections history of cholestatic GI: gonorrhea or syphilis,
RNA-  Treatment of jaundice or hepatic - Abdominal pseudomembranous
dependent uncomplicated dysfuntion from pain colitis, hepatic or renal
protein skin infections prior use of - Anorexia impairment, lactation.
synthesis at  Treatment of azithromycin. - Diarrhea - Asses for patient’s any
the chain nongonococcal - Do not use oral drug - Nausea site of infection; skin
elongation urethritis and in patients with - Vomiting color, lesions;
step. cervicitis pneumonia or in - Pseudomembra orientation, GI output,
 Treatment of those with moderate nous colitis bowel sounds, liver
acute sinusitis to severe illness or - Dyspepsia evaluation; culture and
 Treatment of risk factors such as - Flatulence sensitivity tests of
otitis media cystic fibrosis, - Melena infection, urinalysis,
 Treatment of nosocomially HEPATIC: LFTs, renal function
pharyngitis and acquired infections, - Cholestatic tests.
tonsillitis known or suspected jaundice - Obtain specimen for
 Treatment of bacteremia, SKIN: culture and sensitivity
patients with hospitalized, elderly - Photosensitivit test before giving first
mild to moderate or debilitated y reactions dose. begin therapy
acute bacterial patients or patients - Rash while awaiting results.
sinusitis with - Pruritus - Administer on an
 Treatment of immunodeficiency Other: empty stomach 1 hr
mild to moderate or functional - Angioedema before or 2–3 hr after
community asplenia. meals. Food affects the
acquired absorption of this
pneumonia drug.

After administration:
- Monitor patient for
superinfection.
- Monitor patient for
allergic and skin
reactions. Discontinue
drug if reactions occur.
- Monitor patient for
jaundice,
hepatotoxicity, and
hepatitis. Discontinue
drug immediately if
signs and symptoms
occur.
- Tell patient to take
drug as prescribed,
even after feeling
better.
- Advise patient to
avoid excessive
 sunlight and to wear
protective clothing and
use sunscreen when
outside.
- Tell patient to report
adverse reactions
promptly.
- Advise the patient not
to stop taking drug
without first
contacting health care
provider.